"A Phase 1, Prospective, Randomized, Two-Arm, Active Controlled, Double-Blind Study to Evaluate the Safety and Tolerability of Serum Institute of India's 10-valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Indian Young Adults"

Trial Profile

"A Phase 1, Prospective, Randomized, Two-Arm, Active Controlled, Double-Blind Study to Evaluate the Safety and Tolerability of Serum Institute of India's 10-valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Indian Young Adults"

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Aug 2016

At a glance

  • Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal vaccine
  • Indications Pneumococcal infections
  • Focus Adverse reactions
  • Sponsors Serum Institute of India
  • Most Recent Events

    • 29 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top